Verily

By Dave Muoio 01:46 pm June 24, 2020
Verily and CVS Health are among the latest big names lending their health and technology expertise to reopening businesses. Both companies have announced new enterprise offerings incorporating COVID-19 testing, symptom checking, clinical support, data analysis and app-based tools for employees. Verily's approach, called Healthy at Work, incorporates local, onsite and mail testing services into a...
By Dave Muoio 03:30 pm June 9, 2020
Apple COVID screener now updates the CDC. A COVID-19 screening tool first released by Apple in late March can now report users' symptoms, location, health background and other health characteristics to the CDC. The goal is to help the public health agency aggregate more incidence and case data, which can be used to better inform the public about the disease and its risk factors. These data are...
By Dave Muoio 03:23 pm March 16, 2020
Alphabet's Verily has launched a website where California residents can complete a short survey regarding their current condition and, if they meet certain criteria, could be referred to a nearby mobile COVID-19 testing site. Conducted through Verily's Project Baseline population health effort and developed in collaboration with federal, state and local public health authorities, the triage...
By MobiHealthNews 03:55 pm March 3, 2020
Fitbit and Belgium-based FibriCheck have extended their partnership to bring the latter’s atrial fibrillation detection app to four new countries in the EU: France, Germany, Italy and Spain. It was previously made available to Fitbit smartwatch users in the UK, Ireland, the Netherlands and Belgium back in September 2019. “For more than a decade, Fitbit has helped millions of people around the...
By Dave Muoio 03:22 pm February 26, 2020
Type 2 diabetes patients who received a continuous glucose monitoring (CGM) system as part of a virtual diabetes clinic program improved their HbA1c and near-uniformly said they were comfortable self-inserting a sensor with guidance from a remote coach, according to study data presented by Onduo at an academic conference last weekend. Further, while more than half of the study’s nearly 600...
By Dave Muoio 11:13 am January 22, 2020
Editor's note: This story has been updated with information from Verily's announcement of the clearance.  Verily, the life sciences research subsidiary of Alphabet, has received FDA 510(k) clearance for an augmented version of its prescription Study Watch wearable that includes some form of arrhythmia monitoring. The Study Watch With Irregular Pulse Monitor is classified by the FDA as a “...
By Jonah Comstock 09:49 am January 21, 2020
One of the biggest digital health success stories of the two decades is in the diabetes space, especially the continuous glucose monitor (or CGM). The first CGM was approved by the FDA in 1999, but in the last decade we've seen CGMs become smaller, longer lasting and more comfortable, and we've seen huge strides in datasharing as CGM-phone connectivity went from novelty to commodity.  Dexcom has...
By MobiHealthNews 03:09 pm January 16, 2020
The Digital Therapeutics Alliance, an industry group advocating for the adoption and understanding of evidence-based digital health treatments, has named its new Board of Directors. Representing handful of different digital therapeutics stakeholders, those named are set to hold their positions for a two-year period. Along with Megan Coder, the group’s executive director, the board consists of:...
By Dave Muoio 03:05 pm January 8, 2020
Dr. Vindell Washington, the head on the Office of the National Coordinator for Health IT from August 2016 to January 2017, is the latest to jump on board at Alphabet's Verily, according to tweets from fellow ONC vet-turned-Googler Dr. Karen DeSalvo, as well as from Verily’s communications lead. He comes directly from a position as Blue Cross and Blue Shield of Louisiana’s chief medical officer....
By Dave Muoio 05:01 pm December 13, 2019
It has been a tumultuous week in the realm of digital health partnerships. It started with word of Proteus Digital Health’s floundering business and failed investment round, which reports say was partially driven by cooling relations between the digital pill maker and its longtime patron Otsuka Pharmaceuticals. A few days later, Sanofi announced a company-wide strategy shift that found Onduo, its...